Fate Therapeutics Announces Pricing of Public Offering of Common Stock

Go back to Fate Therapeutics Announces Pricing of Public Offering of Common Stock
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.43 --0 (-0%)
Previous Close $2.43    52 Week High $4.76 
Open $2.43    52 Week Low $1.46 
Day High $2.43    P/E N/A 
Day Low $2.43    EPS $-1.91 
Volume 105,006